GlassScriptPhysician profile
Peter S Filderman
NPI 1245214964
$11,790.86
in general payments reported to CMS, 2019-2025
54 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,846 · 2020: $639 · 2021: $1,116 · 2022: $1,391 · 2023: $3,972 · 2024: $1,453 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,421 · Travel and Lodging: $1,308 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,420.73 |
| Travel and Lodging | $1,308.00 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sn Holdings, LLC | $2,015.00 | 2023 | |
| Astellas Pharma US INC | $1,137.05 | 2019-2024 | Myrbetriq, Xtandi |
| Abbvie INC. | $926.89 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $794.75 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $610.17 | 2019-2025 | |
| Janssen Biotech, INC. | $604.14 | 2019-2025 | Erleada, Akeega |
| Teleflex LLC | $428.81 | 2022-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $383.31 | 2019-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $371.31 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $332.11 | 2022-2025 | Pylarify |
| Urovant Sciences INC | $269.91 | 2021-2022 | |
| Pfizer INC. | $259.21 | 2019-2025 | |
| 180 Medical, INC. | $249.89 | 2019-2025 | Gentlecath, Speedicath |
| Dornier Medtech America, INC | $237.00 | 2023 | Dornier Medtech |
| Ferring Pharmaceuticals INC. | $234.39 | 2019-2024 | Adstiladrin |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $225.61 | 2022-2023 | Axonics |
| Endo Pharmaceuticals INC. | $204.28 | 2019-2021 | |
| Tolmar, INC. | $189.27 | 2023-2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $186.72 | 2021-2025 | Keytruda, Lynparza |
| Urogen Pharma, INC. | $171.93 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $169.77 | 2023-2025 | |
| Neotract INC. | $169.31 | 2019-2020 | |
| Urogpo LLC | $168.05 | 2019 | |
| Myovant Sciences INC. | $145.75 | 2021-2022 | |
| Allergan, INC. | $145.38 | 2019-2021 | |
| Immunitybio, INC. | $135.17 | 2025 | |
| Medtronic, INC. | $106.48 | 2022-2024 | Interstim |
| Amgen INC. | $97.56 | 2019-2022 | |
| Boston Scientific Corporation | $85.66 | 2022-2025 | Spaceoar Vue System - 10ml, Axonics |
| Antares Pharma, INC. | $63.08 | 2019-2022 | |
| Endo USA, INC. | $63.05 | 2024-2025 | Xiaflex, Aveed |
| Bioprotect Medical, INC. | $44.85 | 2024 | Bioprotect Balloon Implant System |
| Tempus Ai, INC | $44.03 | 2024 | Xt Cdx |
| Accord Healthcare, INC. | $43.46 | 2023-2024 | |
| Clarus Therapeutics INC. | $42.73 | 2021 | |
| Blue Earth Diagnostics | $40.44 | 2021 | |
| Foundation Medicine, INC. | $36.37 | 2021-2022 | |
| Coloplast Corp | $34.90 | 2021-2024 | |
| Caris Mpi, INC. | $33.12 | 2025 | Mi Cancer Seek |
| Acerus Pharmaceuticals Corporation | $29.58 | 2021 | |
| Olympus America INC. | $28.10 | 2023 | Itind System |
| Zyla Life Sciences, INC. | $22.68 | 2020 | |
| Convatec INC. | $22.11 | 2021 | |
| Philips North America LLC | $21.23 | 2025 | Disease Management Solutions Equipment Undivided |
| Astrazeneca Pharmaceuticals LP | $19.41 | 2023 | Lynparza |
| Hollister Incorporated | $18.95 | 2023 | Vapro, Infyna Chic |
| Avadel Specialty Pharmaceuticals, LLC | $18.23 | 2019 | |
| Telix Pharmaceuticals | $17.26 | 2024 | Illuccix |
| Metuchen Pharmaceuticals | $16.95 | 2019 | |
| Verity Pharmaceuticals INC. | $16.16 | 2022 | |
| Myriad Genetic Laboratories, INC. | $15.40 | 2021 | |
| Dentsply Ih Ab | $14.76 | 2023 | Lofric |
| Vertex Pharmaceuticals Incorporated | $14.70 | 2025 | |
| Valencia Technologies Corporation | $14.43 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Filderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.